Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fibrinogen concentrate dose-escalation during paediatric cardiopulmonary bypass
2013-003532-68Phase 2Completed
- Sponsor
- Guy's and St Thomas' NHS Foundation Trust
- Start
- Feb 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Fibrinogen human in Bleeding and Cardiovascular Malformation (CVM), sponsored by Guy's and St Thomas' NHS Foundation Trust. Primary endpoints: Fibrinogen concentration and FibTEM MCF. Started Feb 2014; status: completed.
02
Drugs
Fibrinogen human
03
Conditions
BleedingCardiovascular Malformation (CVM)
Beyond the preview
Go deeper on 2013-003532-68.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003532-68.